BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 15500128)

  • 21. [Immunopathology of glomerulonephritis with mesangial IgA deposits].
    Berthoux FC
    Nephrologie; 1989; 10(4):169-74. PubMed ID: 2699007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [IgA1 aberrant glycosylation in the pathogenesis of IgA nephropathy: an overivew].
    Xie L; Wang L; Huang J; Fan J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Feb; 27(1):227-30. PubMed ID: 20337060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of prognosis in IgA nephropathy.
    Tomino Y
    Kaohsiung J Med Sci; 2012 Oct; 28(10):517-20. PubMed ID: 23089315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Haemophilus parainfluenzae antigens in IgA nephropathy].
    Suzuki S; Kimura H; Gejyo F
    Rinsho Byori; 1998 Jan; 46(1):17-25. PubMed ID: 9492534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IgA1 molecules produced by tonsillar lymphocytes are under-O-glycosylated in IgA nephropathy.
    Horie A; Hiki Y; Odani H; Yasuda Y; Takahashi M; Kato M; Iwase H; Kobayashi Y; Nakashima I; Maeda K
    Am J Kidney Dis; 2003 Sep; 42(3):486-96. PubMed ID: 12955676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary IgA nephropathy: new insights into pathogenesis.
    Barratt J; Feehally J
    Semin Nephrol; 2011 Jul; 31(4):349-60. PubMed ID: 21839368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy.
    Allen AC; Harper SJ; Feehally J
    Clin Exp Immunol; 1995 Jun; 100(3):470-4. PubMed ID: 7774058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased cytokine-induced IgA subclass production by CD40-ligated circulating B cells in primary IgA nephropathy.
    de Fijter JW; van Nisselrooij NI; Schroeijers WE; Daha MR; van Es LA; van Kooten C
    Nephrol Dial Transplant; 1998 Feb; 13(2):285-92. PubMed ID: 9509436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The bone marrow as production site of the IgA deposited in the kidneys of patients with IgA nephropathy.
    van den Wall Bake AW; Daha MR; Radl J; Haaijman JJ; Van der Ark A; Valentijn RM; Van Es LA
    Clin Exp Immunol; 1988 May; 72(2):321-5. PubMed ID: 3409549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pathogenesis of Berger's disease: recent advances on the involvement of immunoglobulin A and their receptors].
    Monteiro RC; Leroy V; Launay P; Moura IC; Arcos-Fajardo M; Benhamou M; Haddad E
    Med Sci (Paris); 2003 Dec; 19(12):1233-41. PubMed ID: 14691748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IgA nephropathy and mucosal immune system.
    Nagura H
    Tokai J Exp Clin Med; 1989 Mar; 14(1):1-4. PubMed ID: 2699951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IgA nephropathy enigma.
    Mestecky J; Novak J; Moldoveanu Z; Raska M
    Clin Immunol; 2016 Nov; 172():72-77. PubMed ID: 27444044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunoglobulin A and renal diseases].
    Matousovic K; Mestecky J; Tomana M; Novak J
    Vnitr Lek; 2006 Mar; 52(3):256-62. PubMed ID: 16722157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mesangial IgA2 deposits and lectin pathway-mediated complement activation in IgA glomerulonephritis.
    Hisano S; Matsushita M; Fujita T; Endo Y; Takebayashi S
    Am J Kidney Dis; 2001 Nov; 38(5):1082-8. PubMed ID: 11684563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetics and immunopathogenesis of IgA nephropathy.
    Yu HH; Chu KH; Yang YH; Lee JH; Wang LC; Lin YT; Chiang BL
    Clin Rev Allergy Immunol; 2011 Oct; 41(2):198-213. PubMed ID: 21188648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. O-linked oligosaccharide on IgA1 hinge region in IgA nephropathy. Fundamental study for precise structure and possible role.
    Hiki Y; Horii A; Iwase H; Tanaka A; Toda Y; Hotta K; Kobayashi Y
    Contrib Nephrol; 1995; 111():73-84. PubMed ID: 7758349
    [No Abstract]   [Full Text] [Related]  

  • 37. Glomerular T cell and monocyte populations in patients with IgA nephropathy.
    Tomino Y; Ozaki T; Koide H; Yagame M; Eguchi K; Nomoto Y; Sakai H
    Nihon Jinzo Gakkai Shi; 1989 Feb; 31(2):221-6. PubMed ID: 2786966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microbial IgA protease removes IgA immune complexes from mouse glomeruli in vivo: potential therapy for IgA nephropathy.
    Lamm ME; Emancipator SN; Robinson JK; Yamashita M; Fujioka H; Qiu J; Plaut AG
    Am J Pathol; 2008 Jan; 172(1):31-6. PubMed ID: 18165266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predominant polymeric IgA1 deposition in glomeruli in patients with IgA nephropathy.
    Suzuki S; Kobayashi H; Suzuki Y; Arakawa M
    Nihon Jinzo Gakkai Shi; 1987 Mar; 29(3):271-5. PubMed ID: 3302427
    [No Abstract]   [Full Text] [Related]  

  • 40. Pathogenetic aspects of IgA nephropathy.
    Rantala I; Mustonen J; Hurme M; Syrjänen J; Helin H
    Nephron; 2001 Jul; 88(3):193-8. PubMed ID: 11423748
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.